Dendritic Cell (DC) Therapy or so-called Dendritic Cell vaccine is a newly emerging and potent form of immune therapy used to treat cancer. Dendritic cell therapy is an immune therapy which harnesses the body's own immune system to fight cancer. The dendritic cell itself is an immune cell whose role is the recognition, processing and presentation of foreign antigens to the T-cells in the effector arm of the immune system. Although dendritic cell are potent cells, they are not usually present in adequate quantity to allow for a potent immune response. Dendritic cell therapy thus involves the harvesting of blood cells (monocytes) from a patient and processing them in the laboratory to produce dendritic cells which are then given back to a patient in order to allow massive dendritic cell participation in optimally activating the immune system.

Dendritic Cell Therapy delays cancer progression and improves survival. Dendritic cells (DC) therapy delays cancer progression and improves patient survival. DENvax helps to prevent relapse.It shows most promise at preventing a recurrence of cancer after surgery, chemotherapy or radiation because the immune system will need to recognize and attack a smaller number of cancer cells. Dendritic Cell Therapy can be given in combination with other modalities of cancer treatment. It can be given alone or in combination with the other treatment modalities. Dendritic cell therapy comes under the heading of Biological Therapy of Cancer, the fourth modality of cancer treatment after surgery, radiation and chemotherapy.It has negligible adverse effects or toxicity as compared to chemotherapy .Dendritic Cell Therapy  is customized treatment. It is designed to be safe and has minimal side effects.  The components of Dendritic Cell Therapy include patient's own mononuclear cells manipulated into cancer-fighting dendritic cells; there is no graft versus host reaction, or acute-or delayed-type hypersensitivity.